Abstract:There are thousands of rare human disorders that are caused by single deleterious, protein-coding genetic variants1. However, patients with the same genetic defect can have different clinical presentations2–4, and some individuals who carry known disease-causing variants can appear unaffected5. Here, to understand what explains these differences, we study a cohort of 6,987 children assessed by clinical geneticists to have severe neurodevelopmental disorders such as global developmental delay and autism, often in combination with abnormalities of other organ systems. Although the genetic causes of these neurodevelopmental disorders are expected to be almost entirely monogenic, we show that 7.7% of variance in risk is attributable to inherited common genetic variation. We replicated this genome-wide common variant burden by showing, in an independent sample of 728 trios (comprising a child plus both parents) from the same cohort, that this burden is over-transmitted from parents to children with neurodevelopmental disorders. Our common-variant signal is significantly positively correlated with genetic predisposition to lower educational attainment, decreased intelligence and risk of schizophrenia. We found that common-variant risk was not significantly different between individuals with and without a known protein-coding diagnostic variant, which suggests that common-variant risk affects patients both with and without a monogenic diagnosis. In addition, previously published common-variant scores for autism, height, birth weight and intracranial volume were all correlated with these traits within our cohort, which suggests that phenotypic expression in individuals with monogenic disorders is affected by the same variants as in the general population. Our results demonstrate that common genetic variation affects both overall risk and clinical presentation in neurodevelopmental disorders that are typically considered to be monogenic.

Polygenic architecture of rare coding variation across 394,783 exomes

Rare variant contribution to human disease in 281,104 UK Biobank exomes

Population structure analysis using rare and common functional variants

Systematic single-variant and gene-based association testing of thousands of phenotypes in 394,841 UK Biobank exomes

Whole-exome sequencing in UK Biobank reveals rare genetic architecture for depression

Genome-wide Burden of Deleterious Coding Variants Increased in Schizophrenia

Rare penetrant mutations confer severe risk of common diseases

Rare coding variant analysis for human diseases across biobanks and ancestries

Rare and low-frequency variants in human common diseases and other complex traits

A polygenic burden of rare disruptive mutations in schizophrenia

Common genetic variants contribute to risk of rare severe neurodevelopmental disorders

Investigation of recessive effects of coding variants on common clinical phenotypes in exome-sequenced UK Biobank participants

Analysis of exome sequencing data implicates rare coding variants in STAG1 and ZNF136 in schizophrenia

Substantial role of rare inherited variation in individuals with developmental disorders

Genetic associations of protein-coding variants in human disease

Striking Departures from Polygenic Architecture in the Tails of Complex Traits

Integration of Rare Large-Effect Expression Variants Improves Polygenic Risk Prediction

Protein-altering variants at copy number-variable regions influence diverse human phenotypes

Large-scale whole-exome sequencing of neuropsychiatric diseases and traits in 350,770 adults

A deep catalogue of protein-coding variation in 983,578 individuals

Bayesian Rare Variant Analysis Identifies Novel Schizophrenia Putative Risk Genes